Evidence map›Paper›PMID 32607006›Full record

ArticleJournal of experimental pharmacology2020

Evaluation of in vitro and in vivo Anti-Diabetic, Anti-Hyperlipidemic and Anti-Oxidant Activity of Flower Crude Extract and Solvent Fractions of

Zemene Demelash Kifle, Jibril Seid Yesuf, Seyfe Asrade Atnafie

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Evaluations of theMetabolism open · 2024
    Article
  14. Review
  15. Article
  16. RSC advances · 2024
    Article
  17. Frontiers in pharmacology · 2023
    Article
  18. Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  19. Article
  20. Saudi journal of biological sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zemene Demelash KifleUniversity of Gondar, College of Medicine and Health Sciences, School of Pharmacy, Department of Pharmacology, Gondar, Ethiopia.ORCID 0000-0001-7030-2782
Jibril Seid YesufUniversity of Gondar, College of Medicine and Health Sciences, School of Pharmacy, Department of Pharmacology, Gondar, Ethiopia.ORCID 0000-0003-0784-7119
Seyfe Asrade AtnafieUniversity of Gondar, College of Medicine and Health Sciences, School of Pharmacy, Department of Pharmacology, Gondar, Ethiopia.ORCID 0000-0002-8262-0590
University of Gondar · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe flower of

methodsThe in vitro α-amylase inhibition and antioxidant activity of the crude extract and solvent fractions of

resultsThe acute toxicity study of

conclusionThe result demonstrated the beneficial biochemical effects of

Indexed as

antidiabeticanti-hyperlipidemicantioxidantHagenia abyssinicastreptozotocinα-amylase

Identifiers

PMID32607006
PMCPMC7293407
OpenAlexW3033784036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.